Registrati | Log in | FAQ      [?] 

Oncogene

Articles from the last few issues of Oncogene © Nature Publishing Group
  • Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration
    Oncogene, Vol. aop, No. current.
    by Y Wu, MS Siadaty, ME Berens, GM Hampton, D Theodorescu
  • The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11
    Oncogene, Vol. aop, No. current.
    by C Chen, Z Zhou, R Liu, Y Li, PB Azmi, AK Seth
  • Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
    Oncogene, Vol. aop, No. current.
    by X Li, V Placencio, JM Iturregui, C Uwamariya, AR Sharif-Afshar, T Koyama, SW Hayward, NA Bhowmick
  • Full-length hdmX transcripts decrease following genotoxic stress
    Oncogene, Vol. aop, No. current.
    by M Markey, SJ Berberich
  • Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling
    Oncogene, Vol. aop, No. current.
    by A Pen, MJ Moreno, Y Durocher, P Deb-Rinker, DB Stanimirovic
  • Critical pathways in cellular senescence and immortalization revealed by gene expression profiling
    Oncogene, Vol. aop, No. current.
    by AL Fridman, MA Tainsky
  • Cyclin D1 in low-dose radiation-induced adaptive resistance
    Oncogene, Vol. aop, No. current.
    by KM Ahmed, M Fan, D Nantajit, N Cao, JJ Li
  • Functional long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells
    Oncogene, Vol. aop, No. current.
    by H Duan, H Xiang, L Ma, LM Boxer
  • Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
    Oncogene, Vol. aop, No. current.
    by N Koyama, J Zhang, Huqun, H Miyazawa, T Tanaka, X Su, K Hagiwara
  • Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL
    Oncogene, Vol. aop, No. current.
    by JR Leeman, MA Weniger, TF Barth, TD Gilmore
  • Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression
    Oncogene, Vol. aop, No. current.
    by J Tang, X Yang, X Liu
  • The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition
    Oncogene, Vol. aop, No. current.
    by M Shiono, T Kobayashi, R Takahashi, G Sun, M Abe, D Zhang, L Wang, X Piao, Y Takagi, R Mineki, H Taka, N Tada, S Sonobe, S Momose, M Ueda, O Hino
  • Differences and evolution of the methods for the assessment of microsatellite instability
    Oncogene, Vol. aop, No. current.
    by L Laghi, P Bianchi, A Malesci
  • Evidence for Hox and E2A–PBX1 collaboration in mouse T-cell leukemia
    Oncogene, Vol. aop, No. current.
    by J Bijl, J Krosl, CE Lebert-Ghali, J Vacher, N Mayotte, G Sauvageau
  • Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
    Oncogene, Vol. aop, No. current.
    by YM Chang, L Bai, S Liu, JC Yang, HJ Kung, CP Evans
  • DNA-PKcs and ATM influence generation of ionizing radiation-induced bystander signals
    Oncogene, Vol. aop, No. current.
    by RT Hagelstrom, KF Askin, AJ Williams, L Ramaiah, C Desaintes, EH Goodwin, RL Ullrich, SM Bailey
  • The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice
    Oncogene, Vol. aop, No. current.
    by P Hasselblatt, L Gresh, H Kudo, J Guinea-Viniegra, EF Wagner
  • PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
    Oncogene, Vol. aop, No. current.
    by E Taniguchi, K Nishijo, AT Mccleish, JE Michalek, MH Grayson, AJ Infante, HE Abboud, RD Legallo, SJ Qualman, BP Rubin, C Keller
  • C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
    Oncogene, Vol. aop, No. current.
    by D Zhuang, S Mannava, V Grachtchouk, WH Tang, S Patil, JA Wawrzyniak, AE Berman, TJ Giordano, EV Prochownik, MS Soengas, MA Nikiforov
  • Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures
    Oncogene, Vol. aop, No. current.
    by F Brellier, V Bergoglio, A Valin, S Barnay, O Chevallier-Lagente, P Vielh, A Spatz, P Gorry, MF Avril, T Magnaldo
  • Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background
    Oncogene, Vol. aop, No. current.
    by JH Mao, D Wu, R Delrosario, A Castellanos, A Balmain, J Perez-Losada
  • Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
    Oncogene, Vol. aop, No. current.
    by DW Müller, AK Bosserhoff
  • Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage
    Oncogene, Vol. aop, No. current.
    by A Rebillard, N Rioux-Leclercq, C Muller, P Bellaud, F Jouan, O Meurette, E Jouan, L Vernhet, C Le Quément, A Carpinteiro, M Schenck, D Lagadic-Gossmann, E Gulbins, MT Dimanche-Boitrel
  • Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays
    Oncogene, Vol. aop, No. current.
    by DS Rickman, R Millon, A De Reynies, E Thomas, C Wasylyk, D Muller, J Abecassis, B Wasylyk
  • Lipocalin 2 is required for BCR-ABL-induced tumorigenesis
    Oncogene, Vol. aop, No. current.
    by X Leng, H Lin, T Ding, Y Wang, Y Wu, S Klumpp, T Sun, Y Zhou, P Monaco, J Belmont, A Aderem, S Akira, R Strong, R Arlinghaus
  • Poly(ADP-ribosyl)ation is implicated in the G0–G1 transition of resting cells
    Oncogene, Vol. aop, No. current.
    by M Carbone, MN Rossi, M Cavaldesi, A Notari, P Amati, R Maione
  • Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway
    Oncogene, Vol. aop, No. current.
    by Y Katsuno, A Hanyu, H Kanda, Y Ishikawa, F Akiyama, T Iwase, E Ogata, S Ehata, K Miyazono, T Imamura
  • Pituitary tumor transforming gene 1 regulates Aurora kinase A activity
    Oncogene, Vol. aop, No. current.
    by Y Tong, A Ben-Shlomo, C Zhou, K Wawrowsky, S Melmed
  • hPMC2 is required for recruiting an ERβ coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen
    Oncogene, Vol. aop, No. current.
    by SP Sripathy, LJ Chaplin, NW Gaikwad, EG Rogan, MM Montano
  • PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
    Oncogene, Vol. aop, No. current.
    by J Shen, H Vakifahmetoglu, H Stridh, B Zhivotovsky, KG Wiman
  • Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity
    Oncogene, Vol. aop, No. current.
    by M De Luca, L Brunetto, IA Asteriti, M Giubettini, P Lavia, G Guarguaglini
  • E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity
    Oncogene, Vol. aop, No. current.
    by PS Danielian, LB Friesenhahn, AM Faust, JC West, AM Caron, RT Bronson, JA Lees
  • PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen
    Oncogene, Vol. aop, No. current.
    by S Kotadia, LR Kao, SA Comerford, RT Jones, RE Hammer, TL Megraw
  • MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers
    Oncogene, Vol. aop, No. current.
    by R Luthra, RR Singh, MG Luthra, YX Li, C Hannah, AM Romans, BA Barkoh, SS Chen, J Ensor, DM Maru, RR Broaddus, A Rashid, CT Albarracin
  • Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
    Oncogene, Vol. aop, No. current.
    by KE Tagscherer, A Fassl, B Campos, M Farhadi, A Kraemer, BC Böck, S Macher-Goeppinger, B Radlwimmer, OD Wiestler, C Herold-Mende, W Roth
  • Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein
    Oncogene, Vol. aop, No. current.
    by Y Takagi, T Kobayashi, M Shiono, L Wang, X Piao, G Sun, D Zhang, M Abe, Y Hagiwara, K Takahashi, O Hino
  • Molecular association between β-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/β-catenin signaling
    Oncogene, Vol. aop, No. current.
    by G Upadhyay, W Goessling, TE North, R Xavier, LI Zon, V Yajnik
  • Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype
    Oncogene, Vol. aop, No. current.
    by K Mazan-Mamczarz, PR Hagner, S Corl, S Srikantan, WH Wood, KG Becker, M Gorospe, JD Keene, AS Levenson, RB Gartenhaus
  • Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7
    Oncogene, Vol. aop, No. current.
    by Y Ishikawa, I Onoyama, KI Nakayama, K Nakayama
  • Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling
    Oncogene, Vol. aop, No. current.
    by LE Dow, IA Elsum, CL King, KM Kinross, HE Richardson, PO Humbert
  • RASSF1A interacts with and activates the mitotic kinase Aurora-A
    Oncogene, Vol. aop, No. current.
    by L Liu, C Guo, R Dammann, S Tommasi, GP Pfeifer
  • ABINs inhibit EGF receptor-mediated NF-κB activation and growth of EGF receptor-overexpressing tumour cells
    Oncogene, Vol. aop, No. current.
    by L Huang, L Verstrepen, K Heyninck, A Wullaert, H Revets, P De Baetselier, R Beyaert
  • Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ
    Oncogene, Vol. aop, No. current.
    by JM Brondello, MJ Pillaire, C Rodriguez, PA Gourraud, J Selves, C Cazaux, J Piette
  • A novel fusion 5′AFF3/3′BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma
    Oncogene, Vol. aop, No. current.
    by L Impera, F Albano, C Lo Cunsolo, S Funes, P Iuzzolino, F Laveder, I Panagopoulos, M Rocchi, CT Storlazzi
  • Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions
    Oncogene, Vol. aop, No. current.
    by ER Motrescu, S Blaise, N Etique, N Messaddeq, MP Chenard, I Stoll, C Tomasetto, MC Rio
  • Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
    Oncogene, Vol. aop, No. current.
    by AMS Müller, J Duque, JA Shizuru, M Lübbert
  • Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor
    Oncogene, Vol. aop, No. current.
    by K Hirose, C Abramovich, B Argiropoulos, RK Humphries
  • N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma
    Oncogene, Vol. aop, No. current.
    by MS Hossain, T Ozaki, H Wang, A Nakagawa, H Takenobu, M Ohira, T Kamijo, A Nakagawara
  • DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells
    Oncogene, Vol. aop, No. current.
    by E García-Aragoncillo, J Carrillo, E Lalli, N Agra, G Gómez-López, Pestaña, J Alonso
  • Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcription
    Oncogene, Vol. aop, No. current.
    by R Fukuyama, R Niculaita, KP Ng, E Obusez, J Sanchez, M Kalady, PP Aung, G Casey, N Sizemore
    • Puoi citare questa pagina come: http://www.citeulike.org/journal/oncogene-aop

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.